Sung‐Soo Yoon

963 total citations
42 papers, 364 citations indexed

About

Sung‐Soo Yoon is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, Sung‐Soo Yoon has authored 42 papers receiving a total of 364 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Hematology, 15 papers in Oncology and 14 papers in Molecular Biology. Recurrent topics in Sung‐Soo Yoon's work include Multiple Myeloma Research and Treatments (8 papers), Acute Myeloid Leukemia Research (7 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (6 papers). Sung‐Soo Yoon is often cited by papers focused on Multiple Myeloma Research and Treatments (8 papers), Acute Myeloid Leukemia Research (7 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (6 papers). Sung‐Soo Yoon collaborates with scholars based in South Korea, United States and Japan. Sung‐Soo Yoon's co-authors include Chul Won Jung, Inho Kim, Seonyang Park, Youngil Koh, Junshik Hong, Dong‐Yeop Shin, Youngil Koh, Kihyun Kım, Jörge E. Cortes and Chul Soo Kim and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Scientific Reports.

In The Last Decade

Sung‐Soo Yoon

40 papers receiving 360 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sung‐Soo Yoon South Korea 12 133 96 85 67 56 42 364
Zhixiang Shen China 11 128 1.0× 102 1.1× 109 1.3× 97 1.4× 80 1.4× 38 386
Arnaud Ferraris Italy 11 60 0.5× 55 0.6× 87 1.0× 55 0.8× 49 0.9× 27 350
Alexandria Porcia Haynes United Kingdom 13 135 1.0× 154 1.6× 73 0.9× 65 1.0× 156 2.8× 23 439
Yao‐Chung Liu Taiwan 11 115 0.9× 64 0.7× 73 0.9× 34 0.5× 57 1.0× 32 288
Marina Mantzourani Greece 13 125 0.9× 85 0.9× 151 1.8× 145 2.2× 17 0.3× 48 463
Yongyong Ma China 12 79 0.6× 136 1.4× 84 1.0× 31 0.5× 64 1.1× 33 316
Mohammad Hadi Sadeghian Iran 9 115 0.9× 25 0.3× 125 1.5× 69 1.0× 22 0.4× 35 343
Ìhsan Karadoǧan Türkiye 10 88 0.7× 53 0.6× 27 0.3× 36 0.5× 54 1.0× 26 250
Óscar Fuster Spain 12 173 1.3× 84 0.9× 208 2.4× 44 0.7× 25 0.4× 29 482
Matthew J. Pianko United States 11 162 1.2× 184 1.9× 158 1.9× 34 0.5× 33 0.6× 34 536

Countries citing papers authored by Sung‐Soo Yoon

Since Specialization
Citations

This map shows the geographic impact of Sung‐Soo Yoon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sung‐Soo Yoon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sung‐Soo Yoon more than expected).

Fields of papers citing papers by Sung‐Soo Yoon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sung‐Soo Yoon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sung‐Soo Yoon. The network helps show where Sung‐Soo Yoon may publish in the future.

Co-authorship network of co-authors of Sung‐Soo Yoon

This figure shows the co-authorship network connecting the top 25 collaborators of Sung‐Soo Yoon. A scholar is included among the top collaborators of Sung‐Soo Yoon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sung‐Soo Yoon. Sung‐Soo Yoon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Koh, Young‐Il, Ja Min Byun, Junshik Hong, et al.. (2024). Glofitamab combined with poseltinib and lenalidomide for relapsed/refractory diffuse large B cell lymphoma: Interim analysis of GPL study.. Journal of Clinical Oncology. 42(16_suppl). 7066–7066. 2 indexed citations
2.
Youk, Jeonghwan, Ja Min Byun, Youngil Koh, et al.. (2023). Effects of tertiary palliative care on the pattern of end‐of‐life care in patients with hematologic malignancies in Korea. European Journal Of Haematology. 112(5). 743–755. 6 indexed citations
3.
Kiladjian, Jean‐Jacques, Alessandro M. Vannucchi, Aaron T. Gerds, et al.. (2023). Momelotinib in Myelofibrosis Patients With Thrombocytopenia: Post Hoc Analysis From Three Randomized Phase 3 Trials. HemaSphere. 7(11). e963–e963. 10 indexed citations
4.
Röth, Alexander, Satoshi Ichikawa, Yoshikazu Ito, et al.. (2023). Crovalimab treatment in patients with paroxysmal nocturnal haemoglobinuria: Long‐term results from the phase I/II COMPOSER trial. European Journal Of Haematology. 111(2). 300–310. 10 indexed citations
5.
Byun, Ja Min, Euijin Chang, Chang Kyung Kang, et al.. (2021). Incidence of invasive fungal infection in acute lymphoblastic and acute myelogenous leukemia in the era of antimold prophylaxis. Scientific Reports. 11(1). 22160–22160. 11 indexed citations
6.
Yun, Jae Won, Jisu Oh, Jung Oh Kim, et al.. (2020). Distinct genetic profile with recurrent population-specific missense variants in Korean adult atypical hemolytic uremic syndrome. Thrombosis Research. 194. 45–53. 6 indexed citations
7.
Lee, Sungyoung, Inho Kim, Sung‐Soo Yoon, et al.. (2020). MED-TMA: A clinical decision support tool for differential diagnosis of TMA with enhanced accuracy using an ensemble method. Thrombosis Research. 193. 154–159. 4 indexed citations
8.
Hong, Junshik, Heekyung Park, Suhyun Park, et al.. (2019). Strong association between herpes simplex virus-1 and chemotherapy-induced oral mucositis in patients with hematologic malignancies. The Korean Journal of Internal Medicine. 35(5). 1188–1198. 17 indexed citations
9.
Lee, Je‐Jung, Kihyun Kım, Chang‐Ki Min, et al.. (2018). Venous thromboembolism in relapsed or refractory multiple myeloma patients treated with lenalidomide plus dexamethasone. International Journal of Hematology. 109(1). 79–90. 8 indexed citations
10.
Koh, Youngil, So‐Young Lee, Inho Kim, et al.. (2014). Bortezomib-associated peripheral neuropathy requiring medical treatment is decreased by administering the medication by subcutaneous injection in Korean multiple myeloma patients. Cancer Chemotherapy and Pharmacology. 74(3). 653–657. 11 indexed citations
11.
12.
Lee, Ho Sup, Lee Chun Park, Eun Mi Lee, et al.. (2012). Comparison of Therapeutic Outcomes Between Surgical Resection Followed By R-CHOP and R-CHOP Alone for Localized Primary Intestinal Diffuse Large B-cell Lymphoma. American Journal of Clinical Oncology. 37(2). 182–187. 27 indexed citations
13.
Yi, Hyeon Gyu, Inho Kim, So Yeon Oh, et al.. (2011). DAAM2 polymorphism is closely related to the clinical outcomes of allogeneic hematopoietic stem cell transplantation. Annals of Hematology. 91(4). 571–576. 2 indexed citations
14.
Min, Chang‐Ki, Seok Jin Kim, Je‐Jung Lee, et al.. (2009). The Effect of Bortezomib On Bone Metabolism of Patients with Multiple Myeloma: a Korean Multicenter Prospective Study.. Blood. 114(22). 4871–4871. 2 indexed citations
15.
16.
Lee, Mark Hong, et al.. (2007). Pharmacokinetics and tolerability of intravenous busulfan in hematopoietic stem cell transplantation. Clinical Transplantation. 21(3). 417–422. 6 indexed citations
17.
Na, Im Il, Tak Yun, Keun‐Wook Lee, et al.. (2006). Acute myelogenous Leukemia in the elderly ($\geq$60): retrospective study of 115 patients. The Korean Journal of Internal Medicine. 70(2). 196–206. 2 indexed citations
18.
Kim, Dae Young, et al.. (2004). A case of therapy-related acute lymphoblastic leukemia after 131I -treatment for thyroid papillary carcinoma.. The Korean Journal of Internal Medicine. 66(4). 437–441. 2 indexed citations
19.
Han, Seong‐Su, Kihyun Kım, Eun‐Ryeong Hahm, et al.. (2004). L‐ascorbic acid represses constitutive activation of NF‐κB and COX‐2 expression in human acute myeloid leukemia, HL‐60. Journal of Cellular Biochemistry. 93(2). 257–270. 38 indexed citations
20.
Lee, Keun‐Wook, Jongyoun Yi, Tak Yun, et al.. (2004). Extramedullary Relapse Confirmed by Fluorescence In Situ Hybridization Study of an Ear Mass in Acute Promyelocytic Leukemia. International Journal of Hematology. 79(5). 462–464. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zhixiang Shen Breakdown of academic impact, for papers by Arnaud Ferraris Breakdown of academic impact, for papers by Alexandria Porcia Haynes Breakdown of academic impact, for papers by Yao‐Chung Liu Breakdown of academic impact, for papers by Marina Mantzourani Breakdown of academic impact, for papers by Yongyong Ma Breakdown of academic impact, for papers by Mohammad Hadi Sadeghian Breakdown of academic impact, for papers by Ìhsan Karadoǧan Breakdown of academic impact, for papers by Óscar Fuster Breakdown of academic impact, for papers by Matthew J. Pianko
Rankless by CCL
2026